Skip to main content
Touyun Biotech Group Limited logo

Touyun Biotech Group Limited — Investor Relations & Filings

Ticker · 1332 HKEX Manufacturing
Open in API
Filings indexed 641 across all filing types
Latest filing 2025-08-22 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 1332

About Touyun Biotech Group Limited

http://www.touyunbiotech.com.hk

Touyun Biotech Group Limited operates through two primary business segments: packaging solutions and biotechnology. The packaging division specializes in the design, manufacture, and sale of packaging products, alongside the provision of quick response (QR) code solutions. These services deliver tailor-made, one-stop marketing solutions and Big Data analysis, often employing a "one product one code" system for brand protection and consumer engagement. Concurrently, the Group is engaged in the biotechnology sector, focusing on the cultivation and commercialization of Chlamydomonas Reinhardtii microalgae. This product is positioned as a nutritional supplement, valued for its high content of plant-based protein, omega 3, and dietary fiber. The Group utilizes an exclusive, non-genetically modified cultivation technology and biological fermentation methodology for enclosed, rapid production, ensuring a purely green product free of chemical additives. The supplements target individuals seeking support for cardiovascular health, immunity, and metabolic function, with production processes certified by international food safety authorities.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025' and contains detailed unaudited consolidated financial statements, including the statement of profit or loss, statement of financial position, and notes to the financial information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2025
2025-08-22 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 1% confidence The document is a short announcement notifying shareholders and the market of the date of a board meeting to approve the Company’s interim results. It does not contain the actual interim report (so it is not an Interim/Quarterly Report (IR)), nor does it present or solicit votes at an AGM, or announce management changes (MANG). It also is not a report publication itself (RPA) since no report is attached or published at this time—only a meeting date is given. Therefore this is best categorized as a general regulatory announcement that does not fit other specific categories: Regulatory Filings (RNS).
2025-08-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings Classification · 1% confidence The document is a prescribed monthly return (Form FF301) filed with HKEX under Chapter 19B of the Listing Rules, detailing movements in authorised share capital, issued and treasury shares, share options, etc. It is a mandatory periodic regulatory submission, not an actual financial report (e.g., annual or interim), earnings release, or management discussion. It does not announce a specific corporate action (like a one-off share issue) but rather summarizes all share movements for the month. Therefore, it best fits the fallback category for general regulatory filings.
2025-08-01 English
DISCLOSEABLE TRANSACTION DISPOSAL OF FIXED ASSETS
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement regarding a discloseable transaction under Chapter 14 of the Listing Rules, specifically the disposal of steam pipeline assets for a consideration. It is not an earnings release, annual report, proxy solicitation, M&A takeover, share issuance, interest rate notice, nor executive dealing. It does not present full financial statements or a report publication notice—it is the transaction announcement itself. No other specific category covers asset disposal announcements, so it falls under general regulatory filings (fallback category).
2025-07-31 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 1% confidence The document is a standalone announcement listing the company’s board members and their committee roles as of a specific date. It does not present full financial results, legal matters, or AGM materials, but rather details the composition of the board and its committees. This aligns with Board/Management Information.
2025-07-04 English
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE
Board/Management Information Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement by Touyun Biotech Group Limited regarding changes in the composition of its Nomination Committee, specifically detailing which directors have ceased or assumed roles on the committee and updating the board composition. This is an announcement of changes in the company’s board/committee structure, which falls under "Board/Management Information".
2025-07-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.